Literature DB >> 24669895

A better regulation is required in viral hepatitis smartphone applications.

Ma R Cantudo-Cuenca1, Ma A Robustillo-Cortés2, Ma D Cantudo-Cuenca3, R Morillo-Verdugo3.   

Abstract

AIM: To describe the characteristics and content of the available viral hepatitis mobile applications, as well as assess the level of participation of medical professionals in their development.
METHODS: A descriptive observational study was carried out in September 2013. We searched smartphone apps specifically relating to the viral hepatitis for using a keyword search with the following terms; «hepatitis», «hepatology», «hbv» and «hcv» in the Google Play Store (Android) and the Apple App Store (iOS). Data recorded included: name, platform, category, cost, user star rating, number of downloads, date the app was updated by the developer and target audience. We analysed the content of the applications, and these were then categorised based on the viral hepatitis type into three groups. We conducted an analysis in which we specifically examined the authorship in order to assess the prevalence of health professional participation in their development.
RESULTS: A total of 33 apps were included (from 232 that were identified), among which there were 10 duplicates. Most of these apps were uploaded under the medical category. Three had ratings less than 3.9 stars (out of 5). Only 6 apps had exceeded 1000 downloads. A total of 12 apps were aimed at health professionals, while 4 focused on patients (7 for both of them). The participation of health professionals in the development of apps was 56.6%.
CONCLUSIONS: Viral hepatitis apps are available for both professionals and patients; however, much of the information contained within them is often not validated. They should be certificated. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24669895

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  7 in total

1.  Smartphone Applications for the Clinical Oncologist in UK Practice.

Authors:  Hamoun Rozati; Sonya Pratik Shah; Neha Shah
Journal:  J Cancer Educ       Date:  2015-06       Impact factor: 2.037

Review 2.  Mobile Applications (Apps) to Support the Hepatitis C Treatment: A Systematic Search in App Stores.

Authors:  Aline Teotonio Rodrigues; Camila Tavares Sousa; João Pereira; Isabel Vitória Figueiredo; Tácio de Mendonça Lima
Journal:  Ther Innov Regul Sci       Date:  2020-07-22       Impact factor: 1.778

3.  mHealth in Urology: A Review of Experts' Involvement in App Development.

Authors:  Nuno Pereira-Azevedo; Eduardo Carrasquinho; Eduardo Cardoso de Oliveira; Vitor Cavadas; Luís Osório; Avelino Fraga; Miguel Castelo-Branco; Monique J Roobol
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

4.  Enhancing Pharmacy Student Learning and Perceptions of Medical Apps.

Authors:  Jennifer Rodis; Timothy Dy Aungst; Nicole V Brown; Yan Cui; Leonard Tam
Journal:  JMIR Mhealth Uhealth       Date:  2016-05-12       Impact factor: 4.773

5.  Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis.

Authors:  Roberto Collado-Borrell; Vicente Escudero-Vilaplana; Cristina Villanueva-Bueno; Ana Herranz-Alonso; Maria Sanjurjo-Saez
Journal:  J Med Internet Res       Date:  2020-08-25       Impact factor: 5.428

6.  Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis.

Authors:  Miguel Ángel Amor-García; Roberto Collado-Borrell; Vicente Escudero-Vilaplana; Alejandra Melgarejo-Ortuño; Ana Herranz-Alonso; José Ángel Arranz Arija; María Sanjurjo-Sáez
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-23       Impact factor: 4.773

Review 7.  Expert Involvement and Adherence to Medical Evidence in Medical Mobile Phone Apps: A Systematic Review.

Authors:  Yousif Subhi; Sarah Hjartbro Bube; Signe Rolskov Bojsen; Ann Sofia Skou Thomsen; Lars Konge
Journal:  JMIR Mhealth Uhealth       Date:  2015-07-27       Impact factor: 4.773

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.